Pacemakers can improve heart function in patients with chemotherapy-induced heart disease

BOSTON – With the advent of new therapies, cancer patients are surviving longer than ever before — but the incidence of side-effect chemotherapy-induced cardiomyopathy (CHIC), or weakness of the heart muscle, is increasing. Research published in JAMA has shown that treating CHIC with commercially available cardiac resynchronization therapy (CRT) delivered through a surgically implanted defibrillator…

Details

International Association for the Study of Lung Cancer issues policy statement on e-cigs

DENVER — (November 13, 2019)–The International Association for the Study of Lung Cancer today issued a new policy statement that strongly discourages the use of electronic cigarettes by youth or by adults who are not currently smoking. The IASLC is the world’s largest multidisciplinary lung cancer organization and the new policy statement coincides with Lung…

Details